Genvor Inc. develops AI-assisted peptide discovery technology for agriculture, health and wellness applications. Company news centers on its BioCypher platform, peptide research, sustainable crop-protection technology, human wellness expansion, commercialization partnerships and executive business-development appointments.
Recurring updates include peer-reviewed validation of AGM182 antifungal peptide technology, research collaborations, conference presentations and strategic commercialization frameworks. News also covers Genvor's movement from agriculture-focused peptide programs into broader health, recovery, performance and wellness categories.
News
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of GENVOR (GNVR)?
The current stock price of GENVOR (GNVR) is $0.7633 as of October 1, 2026.
What is the market cap of GENVOR (GNVR)?
The market cap of GENVOR (GNVR) is approximately 15.0M.